|
Volumn 37, Issue 9, 2005, Pages 4001-4005
|
Influence of HLA matching on survival in heart transplantation
|
Author keywords
[No Author keywords available]
|
Indexed keywords
AZATHIOPRINE;
BASILIXIMAB;
CYCLOSPORIN A;
DACLIZUMAB;
HLA A ANTIGEN;
HLA B ANTIGEN;
HLA DR ANTIGEN;
MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER;
OKT 3;
STEROID;
THYMOCYTE ANTIBODY;
ACUTE GRAFT REJECTION;
ADOLESCENT;
ADULT;
AGE DISTRIBUTION;
AGED;
ANALYSIS OF VARIANCE;
CARDIAC GRAFT REJECTION;
CONFERENCE PAPER;
CONTROLLED STUDY;
DIABETES MELLITUS;
FEMALE;
FOLLOW UP;
HEART TRANSPLANTATION;
HISTOCOMPATIBILITY;
HLA MATCHING;
HLA SYSTEM;
HUMAN;
HYPERTENSION;
IMMUNOSUPPRESSIVE TREATMENT;
INCIDENCE;
INFECTION;
KAPLAN MEIER METHOD;
MAJOR CLINICAL STUDY;
MALE;
MORTALITY;
POSTOPERATIVE PERIOD;
PRIORITY JOURNAL;
SCHOOL CHILD;
SEX DIFFERENCE;
SURVIVAL;
ADOLESCENT;
ADULT;
AGED;
ANALYSIS OF VARIANCE;
CHILD;
FEMALE;
FOLLOW-UP STUDIES;
GRAFT REJECTION;
HEART TRANSPLANTATION;
HISTOCOMPATIBILITY TESTING;
HLA ANTIGENS;
HLA-A ANTIGENS;
HLA-B ANTIGENS;
HLA-DR ANTIGENS;
HUMANS;
IMMUNOSUPPRESSIVE AGENTS;
MALE;
MIDDLE AGED;
POSTOPERATIVE COMPLICATIONS;
RETROSPECTIVE STUDIES;
SURVIVAL ANALYSIS;
TIME FACTORS;
TREATMENT OUTCOME;
|
EID: 29544452283
PISSN: 00411345
EISSN: None
Source Type: Journal
DOI: 10.1016/j.transproceed.2005.09.145 Document Type: Conference Paper |
Times cited : (16)
|
References (11)
|